Menu
 
Buscar en la Web Buscar en la Agenda

Agenda

Actividades Académicas
Atrás

XVII INTERNATIONAL SCHOOL OF PHARMACOLOGY ‹TEÓFILO HERNANDO›. FRONTIER THERAPIES IN BRAIN DISEASES: FOCUS ON PURINERGIC SIGNALLING

Información General

Gestiones on-line

Solicitud On Line

Programa

Información General

Procedimiento solicitud onlineProcedimiento solicitud online

Enlace

Código
63U8
Horas

Fecha
23 Jul 2018
27 Jul 2018
Precio
130 € Tarifa C
Tipo
Escuela
Temática
Medicina y Ciencias de la Salud
ECTS
1

Sede donde se gestiona

Santander

Lugar de impartición

Santander - Península de la Magdalena

Dirección

Tobias Engel
Royal College of Surgeons in Ireland, Dublin, Ireland

Antonio G. García
Instituto Fundación Teófilo Hernando de I+D del Medicamento
Universidad Autónoma de Madrid, Madrid, Spain


Secretaría

Luis Gandía Juan
Instituto Fundación Teófilo Hernando de I+D del Medicamento
Universidad Autónoma de Madrid, Madrid, Spain


COLABORACIÓN


COLABORACIÓN

Descripción de la actividad

The International School of Pharmacology “Teófilo Hernando” of the Universidad Internacional Menéndez Pelayo (UIMP) took this name to honour the memory of Professor Teófilo Hernando who, at the beginning of the XX century, introduced pharmacology as an academic subject and as a science at Spanish University. The School was started in 1996. Since then, 16 editions on different medical themes have been run. This XVII edition is monographically dedicated to frontier therapeutic and biomarker discoveries in chronic diseases focusing on purinergic signalling.  

Classically, the School is organised in 10 morning sessions in which renowned international scientists participate as speakers. In the afternoon sessions, 24 young researchers present short communications followed by ample discussions, on their predoctoral or postdoctoral work. 

This 17th edition focuses on early pathogenic features and therapeutic aspects of chronic diseases in particular brain diseases. The interest in early diagnosis and in finding a therapy that delays disease progression are central stage of this School. 

The enormous burden of brain diseases to society is growing due to population ageing. Thus, we expect that deep analysis of frontier knowledge and live debates, two characteristics of this School, will shed light on pathogenic mechanisms and the therapeutic perspectives to mitigate such burden to patients and their families.